相似文献
1
Candidate chromosome 1 disease susceptibility genes for Sjogren's syndrome xerostomia are narrowed by novel NOD.B10 congenic mice.
Clin Immunol. 2014 Jul;153(1):79-90. doi: 10.1016/j.clim.2014.03.012. Epub 2014 Mar 29.
2
Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome.
Arthritis Res Ther. 2012 Feb 27;14(1):R40. doi: 10.1186/ar3753.
3
Genetic analysis of autoimmune sialadenitis in nonobese diabetic mice: a major susceptibility region on chromosome 1.
J Immunol. 2002 Apr 15;168(8):4192-201. doi: 10.4049/jimmunol.168.8.4192.
4
Identification of possible candidate genes regulating Sjögren's syndrome-associated autoimmunity: a potential role for TNFSF4 in autoimmune exocrinopathy.
Arthritis Res Ther. 2008;10(6):R137. doi: 10.1186/ar2560. Epub 2008 Nov 25.
5
Differential gene expression in the salivary gland during development and onset of xerostomia in Sjögren's syndrome-like disease of the C57BL/6.NOD-Aec1Aec2 mouse.
Arthritis Res Ther. 2009;11(2):R56. doi: 10.1186/ar2676. Epub 2009 Apr 20.
6
Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.
Arthritis Rheum. 2002 May;46(5):1390-8. doi: 10.1002/art.10258.
7
Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy.
J Rheumatol. 2000 Aug;27(8):1896-904.
8
Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease.
J Autoimmun. 2006 Mar;26(2):90-103. doi: 10.1016/j.jaut.2005.11.004. Epub 2006 Jan 18.
9
Primary Sjögren's syndrome and deficiency of ICA69.
Lancet. 2002 Oct 5;360(9339):1063-9. doi: 10.1016/S0140-6736(02)11144-5.
10
IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjögren's syndrome-like disease of the nonobese diabetic mouse.
J Immunol. 2007 Jul 1;179(1):382-90. doi: 10.4049/jimmunol.179.1.382.
引用本文的文献
1
Integration of metabolomics and network pharmacology to reveal the protective mechanism underlying Qibai Pingfei capsule on chronic obstructive pulmonary disease.
Front Pharmacol. 2023 Oct 18;14:1258138. doi: 10.3389/fphar.2023.1258138. eCollection 2023.
2
The roles of COX-2 in protozoan infection.
Front Immunol. 2023 Feb 16;14:955616. doi: 10.3389/fimmu.2023.955616. eCollection 2023.
3
Mouse Models of Primary Sjogren's Syndrome.
Curr Pharm Des. 2015;21(18):2350-64. doi: 10.2174/1381612821666150316120024.
4
The osteopontin transgenic mouse is a new model for Sjögren's syndrome.
Clin Immunol. 2015 Mar;157(1):30-42. doi: 10.1016/j.clim.2014.12.010. Epub 2015 Jan 5.
本文引用的文献
1
Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome.
Nat Genet. 2013 Nov;45(11):1284-92. doi: 10.1038/ng.2792. Epub 2013 Oct 6.
2
The RasGAP gene, RASAL2, is a tumor and metastasis suppressor.
Cancer Cell. 2013 Sep 9;24(3):365-78. doi: 10.1016/j.ccr.2013.08.004.
3
The immune factors involved in the pathogenesis, diagnosis, and treatment of Sjogren's syndrome.
Clin Dev Immunol. 2013;2013:160491. doi: 10.1155/2013/160491. Epub 2013 Jul 9.
4
The Interferon-Signature of Sjögren's Syndrome: How Unique Biomarkers Can Identify Underlying Inflammatory and Immunopathological Mechanisms of Specific Diseases.
Front Immunol. 2013 Jul 5;4:142. doi: 10.3389/fimmu.2013.00142. eCollection 2013.
5
CluGene: A Bioinformatics Framework for the Identification of Co-Localized, Co-Expressed and Co-Regulated Genes Aimed at the Investigation of Transcriptional Regulatory Networks from High-Throughput Expression Data.
PLoS One. 2013 Jun 18;8(6):e66196. doi: 10.1371/journal.pone.0066196. Print 2013.
6
Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.
Neurochem Int. 2013 Oct;63(4):322-30. doi: 10.1016/j.neuint.2013.06.012. Epub 2013 Jun 25.
7
Regulation of Torsin ATPases by LAP1 and LULL1.
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):E1545-54. doi: 10.1073/pnas.1300676110. Epub 2013 Apr 8.
8
Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer.
Breast Cancer Res. 2013 Mar 28;15(2):R28. doi: 10.1186/bcr3407.
9
Rituximab therapy for primary Sjögren's syndrome: an open-label clinical trial and mechanistic analysis.
Arthritis Rheum. 2013 Apr;65(4):1097-106. doi: 10.1002/art.37850.
10
Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way.
Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9505-10. doi: 10.1073/pnas.1118458109. Epub 2012 May 30.
Zotero 插件